Valion Bio, Inc. Inventory Write-down
Valion Bio, Inc. (VBIO) reported Inventory Write-down of $230.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2025-11-14
- Valion Bio, Inc. inventory write-down for the quarter ending 2024-12-31 was $338.00K.
- Valion Bio, Inc. inventory write-down for the quarter ending 2021-12-31 was $0.00.
- Valion Bio, Inc. inventory write-down for the quarter ending 2021-09-30 was $0.00.
- Valion Bio, Inc. inventory write-down for the quarter ending 2021-06-30 was $0.00.
- Valion Bio, Inc. inventory write-down for fiscal 2024 was $354.00K, a 1006.25% increase from fiscal 2023.
- Valion Bio, Inc. inventory write-down for fiscal 2023 was $32.00K.
- Valion Bio, Inc. inventory write-down for fiscal 2021 was -$8.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2025-09-30 | $230.00K 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $354.00K 10-K · filed 2025-03-21 | ||
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $32.00K 10-K · filed 2025-03-21 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | -$8.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$8.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$8.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$8.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |